Financhill
Back

Lumos Pharma Quote, Financials, Valuation and Earnings

Lumos Pharma Price Quote

$4.35
+0.01 (+0.23%)
(Updated: December 12, 2024 at 5:30 AM ET)

Lumos Pharma Key Stats

Sell
44
Lumos Pharma (LUMO) is a Sell

Day range:
$4.33 - $4.39
52-week range:
$1.37 - $4.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
16.06
P/B ratio:
7.64%

Volume:
481.7K
Avg. volume:
116.3K
1-year change:
48.63%
Market cap:
$37.5M
Revenue:
$2.1M
EPS:
$-4.29

How Much Does Lumos Pharma Make?

Is Lumos Pharma Growing As A Company?

  • What Is Lumos Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 102.71%
  • What Is Lumos Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Lumos Pharma Stock Price Performance

  • Did Lumos Pharma Stock Go Up Last Month?
    Lumos Pharma share price went down by -0.69% last month
  • Did LUMO's Share Price Rise Over The Last Year?
    LUMO share price rose by 48.63% over the past 1 year

What Is Lumos Pharma 52-Week High & Low?

Lumos Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lumos Pharma?

  • How Much Debt Does Lumos Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Lumos Pharma Have?
    Cash and short term investments quarterly total is $13.5M
  • What Is Lumos Pharma’s Book Value Per Share?
    Book value per share is 0.57

Is Lumos Pharma Cash Flow Positive?

  • What Is LUMO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$31.7M
  • What Is Lumos Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.5M
  • What Is Lumos Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $7.2M

Lumos Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    LUMO return on invested capital is -182.95%
  • What Is Lumos Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -112.43%
  • What Is LUMO Return On Equity?
    ROE is a measure of profitability and is -182.95%

Lumos Pharma Earnings Date & Stock Price

  • What Is Lumos Pharma's Stock Price Today?
    A single share of LUMO can be purchased today for 4.34
  • What Is Lumos Pharma’s Stock Symbol?
    Lumos Pharma trades on the nasdaq under the ticker symbol: LUMO
  • When Is Lumos Pharma’s Next Earnings Date?
    The next quarterly earnings date for Lumos Pharma is scheduled on March 7, 2025
  • When Is LUMO's next ex-dividend date?
    Lumos Pharma's next ex-dividend date is December 12, 2024
  • How To Buy Lumos Pharma Stock?
    You can buy Lumos Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Lumos Pharma Competitors

  • Who Are Lumos Pharma's Competitors?
    Below is a list of companies who compete with Lumos Pharma or are related in some way:
    • Boston Scientific Corp (BSX)
    • Calidi Biotherapeutics Inc (CLDI)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Lumos Pharma Dividend Yield

Lumos Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 10271.43% 186.67%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 4.25
Downside from Last Price: -2.07%

Major Shareholders

  • How many LUMO shares are owned by institutional investors?
    2.4M LUMO shares are owned by institutional investors
  • How many LUMO shares are owned by insiders?
    1.4M LUMO shares are owned by insiders